EFX的耐受性良好，最常见的不良事件是1级或2级胃肠道事件（腹泻、恶心和食欲增加）。 1例接受EFX治疗的患者因恶心而停药，1例在撤回同意后停药。

Equifax Inc (NYSE:EFX) showcases robust revenue growth and operational efficiency in its latest quarterly report. Strategic positioning in credit information services and workforce solutions ...

Investing.com - TD Cowen 对 Akero Therapeutics (NASDAQ: AKRO) 启动覆盖，给予买入评级，目标价为 76.00 美元。根据 InvestingPro 数据，这与分析师的强烈共识一致，目标价范围在每股 60 美元至 109 美元之间。该公司股票表现出令人印象深刻的增长势头，过去一年回报率达 92%。

Equifax Inc. Annual stock financials by MarketWatch. View the latest EFX financial statements, income statements and financial ratios.

Akero Therapeutics (AKRO) announced publication of 96-week final results from the Phase 2b HARMONY trial in The Lancet in adults with ...

Guitarist, composer, and arranger Chieli Minucci is longtime leader of the Grammy-nominated jazz-fusion group CHIELI MINUCCI & SPECIAL EFX, a major force on the jazz and world music scene for well ...

Results support potential of efruxifermin (EFX) to reduce risk of fibrosis progression in patients with pre-cirrhotic (F2-F3) MASH ...